Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis
- 20 December 2007
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 255 (1) , 64-69
Abstract
Hyperhomocysteinemia (HHcy) has been associated with cognitive impairment in various neurological diseases. Cognitive impairment occurs early in multiple sclerosis (MS). Conflicting data have been reported regarding plasma total homocysteine (tHcy) levels in MS patients, and the impact of HHcy on cognitive impairment in MS is not known. This study investigated whether plasma total homocysteine levels are increased in MS and if HHcy is associated with cognitive impairment in MS. We compared tHcy levels in 94 patients with MS and 53 healthy age-matched controls. We used a neuropsychological test battery that included the Raven’s Coloured Progressive Matrices, the Visual Search Test, the Trail Making Test A and B, the Immediate and Delayed Recall of a Short Story, the 30 Paired Word Associates, the Rey-Osterrieth Complex Figure Test, and the Semantic and Verbal Fluency Tests. Clinical (sex, age, type of MS, relapse, disease duration, coexisting disease, smoking habit, and physical disability) and laboratory variables (HHcy, low serum levels of folate and vit.B12, MTHFR genotype) were evaluated for their ability to predict cognitive impairment. The mean tHcy was higher in patients (13.19 μmol/L, SD5.58) than in controls (9.81 μmol/L, SD2.53; p < 0.001). Univariate analysis determined the following factors to be associated with cognitive impairment: higher age at observation, chronic progressive course of disease, longer disease duration,moderate or severe physical disability, and frequency of HHcy. With multivariate regression analysis, there remained a significant association only between frequency of HHcy and cognitive impairment (β 0.262, p = 0.01). We conclude that tHcy levels are increased in MS and that HHcy is associated with cognitive impairment in this disease.Keywords
This publication has 27 references indexed in Scilit:
- Plasma homocysteine levels in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Annals of Neurology, 2005
- Homocysteine in relation to cognitive performance in pathological and non-pathological conditionsClinical Chemistry and Laboratory Medicine (CCLM), 2005
- Homocysteine, white matter hyperintensities, and cognition in healthy elderly peopleAnnals of Neurology, 2002
- Rey-Osterrieth complex figure: normative values in an Italian population sampleNeurological Sciences, 2002
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- HOMOCYSTEINE METABOLISMAnnual Review of Nutrition, 1999
- Trail making test: normative values from 287 normal adult controlsThe Italian Journal of Neurological Sciences, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Rating neurologic impairment in multiple sclerosisNeurology, 1983